| 发明名称 | Modulators of cortical dopaminergic- and NMDA-receptor-mediated glutamatergic neurotransmission | ||
| 摘要 | The present invention relates to novel substituted phenoxyethylamine derivatives, useful as modulators of cortical and basal ganglia dopaminergic and N-methyl-D-aspartate (NMDA) receptor-mediated glutamatergic neurotransmission. In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention. | ||
| 申请公布号 | US9120728(B2) | 申请公布日期 | 2015.09.01 |
| 申请号 | US201514603661 | 申请日期 | 2015.01.23 |
| 申请人 | Integrative Research Laboratories Sweden AB | 发明人 | Sonesson Clas;Karlsson Jonas;Svensson Peder |
| 分类号 | C07D211/22;C07D295/088;C07D205/04;C07C317/22 | 主分类号 | C07D211/22 |
| 代理机构 | Ballard Spahr LLP | 代理人 | Ballard Spahr LLP |
| 主权项 | 1. A phenoxy-ethyl-amine derivative, wherein the phenoxy-ethyl-amine derivative is N-[2-(3-fluoro-5-methylsulfonyl-phenoxy)ethyl]propan-1-amine, or a pharmaceutically acceptable salt thereof. | ||
| 地址 | Göteborg SE | ||